Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2019 May;85(5) > Minerva Anestesiologica 2019 May;85(5):465-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

EDITORIAL   Freefree

Minerva Anestesiologica 2019 May;85(5):465-7

DOI: 10.23736/S0375-9393.19.13711-X

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Why do we give “orphan” approval to biologic therapies but not to extracorporeal blood purification therapies for hyperinflammatory syndromes?

Christopher M. HORVAT, Joseph A. CARCILLO

Division of Pediatric Critical Care Medicine, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA



top of page